Stockreport

Pfizer Canada and BioNTech Receive Health Canada Approval of Omicron KP.2 Variant Adapted COVID-19 Vaccine [Yahoo! Finance]

BioNTech SE - American Depositary Shares  (BNTX) 
PDF It is expected to be available in Canada in the coming weeks. The updated COVID-19 vaccine is tailored to the KP.2 strain of the SARS-CoV-2 Omicron JN.1 lineage. KIR [Read more]